The BCB SARCOMES database is a clinical and biological national database dedicated to sarcoma that contains 3 main databases with specific aims: the first is the pathology database (French expert network dedicated to the management of bone sarcomas \[RESOS\] / French expert network dedicated to the pathology of sarcomas \[RREPS\]), dedicated to systematic review of mesenchymal tumor diagnostics nationwide; the second is clinical (RESOS / French expert clinical network for sarcomas \[NETSARC\]), collecting multidisciplinary tumor boards (MDTB) data of patients nationwide, and the third (CONTICABASE / BONE / GIST) is dedicated to collecting patients longitudinal/follow up data, with a focus on treatments of every events, and a catalogue of associated samples. Primary objectives of BCB-SARCOMES are the following: description of the patterns of care and treatment outcomes, assessment of the prognostic factors of patients' outcomes. With the financial support of the French National Cancer Institute \[Institut National du cancer \[INCa\]).
Study Type
OBSERVATIONAL
Enrollment
150,000
treatment as per standard of care
treatment as per standard of care
treatment as per standard of care
treatment as per standard of care
treatment as per standard of care
Institut Bergonié, Comprehensive Cancer Center
Bordeaux, France
RECRUITINGCentre Léon Bérard
Lyon, France
RECRUITINGInstitut Gustave Roussy, Comprehensive Cancer Center
Villejuif, France
RECRUITINGTime to next treatment (TNT)
Time from the systemic treatment onset to the next treatment or death due to any cause, whichever comes first. When neither death nor new systemic therapy is observed, TNT is censored at the date of last patient contact.
Time frame: 2 years
Time to next treatment (TNT)
Time from the systemic treatment onset to the next treatment or death due to any cause, whichever comes first. When neither death nor new systemic therapy is observed, TNT is censored at the date of last patient contact.
Time frame: 5 years
Overall survival (OS)
Interval between diagnosis and the time of death. When death is not observed, OS is censored at the date of last patient contact.
Time frame: 2 years
Overall survival (OS)
Interval between diagnosis and the time of death. When death is not observed, OS is censored at the date of last patient contact.
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.